NextCure

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NextCure and other ETFs, options, and stocks.

About NXTC

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. 

CEO
Michael S. Richman
CEOMichael S. Richman
Employees
82
Employees82
Headquarters
Beltsville, Maryland
HeadquartersBeltsville, Maryland
Founded
2015
Founded2015
Employees
82
Employees82

NXTC Key Statistics

Market cap
60.83M
Market cap60.83M
Price-Earnings ratio
-0.99
Price-Earnings ratio-0.99
Dividend yield
Dividend yield
Average volume
698.95K
Average volume698.95K
High today
$2.28
High today$2.28
Low today
$1.82
Low today$1.82
Open price
$1.90
Open price$1.90
Volume
1.02M
Volume1.02M
52 Week high
$2.28
52 Week high$2.28
52 Week low
$0.98
52 Week low$0.98
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.